News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Qualyst, Inc. and SOLVO Biotechnology Announce Alliance



12/5/2007 7:57:44 AM

Solvo Biotechnology, a leading provider of drug transport technologies, cell products and contract in vitro and in vivo laboratory services, and Qualyst, Inc., a leader in the development and commercialization of novel and proprietary absorption, distribution, metabolism, excretion and toxicity (ADMET) technologies, today announced that Solvo has obtained a license to Qualyst’s B CLEAR® system. B-CLEAR® products and services are projected to be available in Europe from Solvo in early 2008. Financial details were not disclosed.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES